This (Mostly) Wasn’t Trump’s Week for Making Friends
The world is clearly witnessing exactly how President Donald Trump plans to handle global disagreements.
The Biggest Biotech Build of its Kind
One industry is spending tons of money to address an epidemic that affects millions. And the upside is nearly limitless…
Time to Be Greedy with Defense Stocks
We're going to take a closer look at the defense stocks and try to figure out if now is the…
We Have a Rare Earths Deal
A natural resources deal could be a global game changer than most people understand.
Get Ready for Some Short-Term Pain Before Long-Term Gains
While there are some distressed Americans in the current economy, we believe it will be worth it in the long…
A Green-Energy Play To Plug Into Your Income Portfolio
Under the new Trump administration, there is a company worth looking at.
The IRS Downsizes, Walmart Worries, and Germany Votes
Many investment-affecting news stories broke last week… And these are the ones we are paying attention to.
Prepare for ‘Headline Risk’
Marc Chaikin shows why we're living in an era of "headline risk" But looking beyond the headlines, Marc sees opportunity...
Humanoid Robots for $0.40 an Hour
Humanoid robots are rapidly entering the limelight. And it is worth investing in some players.
It’s Time to Remember the Grave Dancer
We are coming out of a trying time and looking at a recession, which means it's time to revisit a…